- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 4.22M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $113K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $32K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $96K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$2.91M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$2.92M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.14M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.23M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $61K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $131K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $393K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $558K |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 4.22M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$116K |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.02 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $89K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $126K |
| Net Income | Q1 2025 · Mar 31, 2024 | $70K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$215K |